- 市販後調査
- QOL
Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma
Palmer JD, et al.: Front Oncol. 2021 Dec 2;11:772261. doi: 10.3389/fonc.2021.772261. eCollection 2021.
Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma
Palmer JD, et al.: Front Oncol. 2021 Dec 2;11:772261. doi: 10.3389/fonc.2021.772261. eCollection 2021.
Patient Reported Outcome (PRO) Among High-Grade Glioma Patients Receiving TTFields Treatment: A Two Center Observational Study
Onken J, et al.: Front Neurol. 2019 Oct 1;10:1026. doi: 10.3389/fneur.2019.01026. eCollection 2019.
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial
Taphoorn MJB, et al.: JAMA Oncol. 2018 Apr 1;4(4):495-504. doi: 10.1001/jamaoncol.2017.5082.
Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
Ram Z, et al.: Front Oncol. 2021 Sep 27;11:671972. doi: 10.3389/fonc.2021.671972. eCollection 2021.